![CAS:{{0}}|4,10-Dioxatriciklo[5.2.1.0(2,6)]dec-8-ene-3,5-dyon](/uploads/202335855/cas-5426-09-5-4-10-dioxatricyclo-5-2-1-0-2-6a96ddbf74-8214-4d7e-8ee9-f83d99103ae7.jpg)
![CAS:5426-09-5 | 4,10-Dioxatricyclo[5.2.1.0(2,6)]dec-8-ene-3,5-dione](/uploads/202335855/cas-5426-09-5-4-10-dioxatricyclo-5-2-1-0-2-6a726d33d2-e31c-4250-a83a-79212f4aa156.jpg)
![CAS:5426-09-5 | 4,10-Dioxatricyclo[5.2.1.0(2,6)]dec-8-ene-3,5-dione](/uploads/202335855/cas-5426-09-5-4-10-dioxatricyclo-5-2-1-0-2-6ad8990b56-2a9d-44c6-b376-81e0fbbb75e2.jpg)
CAS:{{0}}|4,10-Dioxatriciklo[5.2.1.0(2,6)]dec-8-ene-3,5-dyon
Fòmil molekilè: C8H6O4
Pwa molekilè: 166.13g / mol
Pite: 95 pousan
Pake: 5g / 10g / 25g / 50g / pake esansyèl
Transpò: FeDex / DHL / Oseyan anbake / kondisyon kliyan
- Livrezon atravè lemond
- Kalite asirans
- Sèvis Kliyan 24/7
Pwodwi Entwodiksyon
Aplikasyon
4,10-Dioxatriciklo[5.2.1.0(2,6)]dec-8-ene-3,5-dyon(CAS:{{11} }) te etidye pou aplikasyon potansyèl li yo nan jaden an nan chimi medsin. An patikilye, li te envestige pou potansyèl li yo anti-enflamatwa, antioksidan, ak aktivite antifonjik. Anplis de sa, li te etidye pou kapasite li nan anpeche kwasans sèten kalite selil kansè yo. Li te tou etidye pou itilizasyon potansyèl li nan tretman divès maladi, tankou dyabèt, maladi kadyovaskilè, ak maladi newolojik.
Spesifikasyon
|
ATIK |
SPESIFIKASYON |
|
Non IUPAC |
4,10-dioxatriciklo[5.2.1.02,6]dec-8-ene-3,5-dyon |
|
MDL No |
MFCD00077442 |
|
Pwen bouyi |
372 degre nan 760 mmHg |
|
Flash Point |
172.2±27.9 degre |
|
Dansite |
1.5±0.1 g/cm3 |
|
PSA |
52.60 |
|
LogP |
-0.77 |
|
Aparans |
Blan blan blan (solid) |
|
Presyon vapè |
{{0}}.0±0.8 mmHg nan 25 degre |
|
Endèks refraktif |
1.584 |
|
Kondisyon depo |
Atmosfè inaktif, 2-8 degre |
|
InChI |
InChI=1S/C8H6O4/c9-7-5-3-1-2-4(11-3)6(5)8(10)12-7/h1-6H |
|
InChiKey |
QQYNRBAAQFZCLF-UHFFFAOYSA-N |
Baj popilè: cas:{{0}}|4,10-dioxatriciklo[5.2.1.0(2,6)]dec-8-ene-3,5-dione, pri, sitasyon, rabè, nan stock, pou vann
